An industry for healthy lives

Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region.

News & press releases

Vaccines Europe Paper: Improving Access and Convenience to Vaccination

2018 06 21 Written by Vaccines Europe

Vaccination is one of the most cost-effective public health interventions ever implemented, significantly decreasing the worldwide incidence of numerous deadly diseases and associated mortality. To ensure the continuous and optimal protection of all citizens against infectious vaccine-preventable diseases, taking into consideration the ageing population, better access to immunisation should be ensured and provided throughout Europe. Expanding convenient access to vaccine administration should go together as a shared responsibility to vaccinate with all other Health Care Providers, HCPs (Doctors/GPs, nurses, midwives, pharmacists etc).

Find the VE paper on Improving Access and Convenience to Vaccination here.

Early Career Research Prize in Vaccinology R&D – 2nd edition

2018 05 03 Written by Vaccines Europe

The Early Career Research Prize in Vaccinology R&D is awarded by the International Union of Immunological Societies (IUIS) with the contribution of Vaccines Europe. The objective is to promote and foster a younger generation of scientists in the early stages of their career.

The prize rewards significant achievements in Vaccine R&D, including the discovery of new vaccine antigens, new vaccines design, understanding the basics of the immune response, new technologies that will improve the future of vaccines and vaccination and that are supported by proof-of-concept data (preclinical and clinical).

For information regarding application criteria, follow this link and the Promotion Flyer.

IMI: celebrating 10 years of medical innovations

2018 05 02 Written by Vaccines Europe

The Innovative Medicines Initiative (IMI) is celebrating its 10th anniversary with a high-level event. Organised jointly by IMI together with the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA), the event will take place at the European Commission’s Charlemagne Building in Brussels, Belgium on Wednesday 27 June 2018 from 13:00 to 18:00.

Read more…

Vaccines Europe statement on the European Commission Proposal for a Council Recommendation on Strengthened Cooperation against Vaccine Preventable Diseases

2018 04 26 Written by Vaccines Europe

Vaccines Europe welcomes the European Commission Proposal for a Council Recommendation and the Commission Communication on Strengthened Cooperation against Vaccine Preventable Diseases. See the full statement here.

Page 2 of 2012345...1020...Last »